Navigation Links
Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
Date:9/28/2009

Grand Rapids, Mich. (Sept. 28, 2009) Van Andel Research Institute (VARI) researchers are one step closer to finding new ways to treat Myelodysplastic Syndrome (MDS), a bone marrow disease that strikes up to 15,000 people each year in the United States, and that sometimes results in acute myeloid leukemia. Researchers found that the gene RhoB is important to the disease's progression and could prove to be a therapeutic target for late-stage MDS.

"Using our genetic models, we've been able to provide a better understanding of underlying molecular defects that drive the malignant progression of MDS," said VARI Distinguished Scientific Investigator Art Alberts, Ph.D., whose laboratory recently published its findings in the journal PLoS ONE. "The genes that we've focused on in this study might have a role not only in leukemia, but in solid tumors as well."

Alberts' lab previously reported that the Drf1 gene is crucial to the development of MDS. In its recent study, the lab found that the RhoB gene is important as well; lack of the proteins that are the product of the gene accelerates the disease's progression. The researchers believe examining RhoB levels in samples from patients with advanced MDS could help direct them to better treatment options.

"Our goal is to identify novel therapeutic targets and develop new drugs that affect their activity, but also to find ways to improve upon existing therapeutic strategies that are often associated with deleterious side effects," said Alberts.

"This recent work of Dr. Alberts builds on earlier knowledge from his laboratory yielding important insights into how the body controls the growth of red blood cells," said VARI President and Research Director Dr. Jeffrey Trent. "This breakthrough in our knowledge has the potential to provide us with both new avenues of research, as well as new insights to develop improved treatments for MDS, and other disorders."

In MDS, cells in the bone marrow don't create enough blood cells, and many of the blood cells they do create are abnormal. The body destroys the abnormal blood cells, resulting in low blood counts that can lead to fatigue, impaired immunity, easy bruising and bleeding, and other symptoms. According to the American Cancer Society, 80 to 90 % of all patients with MDS are older than 60 years. In about one third of patients, MDS turns into acute myeloid leukemia, a fast-growing bone marrow cancer.

Lead author of the study Aaron DeWard said that the genetic models that the lab is using are key to translating their discoveries into therapies. "The models allow us to identify and test novel therapeutics and ask more clinically relevant questions," said DeWard.


'/>"/>

Contact: Joe Gavan
616-234-5390
Van Andel Research Institute
Source:Eurekalert

Related medicine news :

1. 30th Anniversary Edition of Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever
2. 46664 and the Nelson Mandela Foundation Call for Establishment of Global Mandela Day
3. American Academy of Orthopaedic Surgeons Appoints Peter Mandell, MD, Chair of the Council on Advocacy
4. Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
5. Nelson Mandelas Favorite African Folktales to be Produced as Audiobook Featuring Archbishop Tutu, Gillian Anderson, America Ferrera, Whoopi Goldberg, Samuel L. Jackson, Alan Rickman and Jurnee Smollett, Directed by Alfre Woodard
6. VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U.S.
7. Shareholder Class Action Filed Against Candela Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Van Andel Institute and Childrens Memorial Research Center of Chicago Form a Partnership to Facilitate Pediatric Research
9. Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant
10. Cambridge Healthtech Institute and Bio-IT World Launch a New eNewsletter: Pharma Services News
11. Integrated Benefits Institute Launches Productivity Modeling Tools to Help Employers Estimate the Impact of Absent Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is revolutionizing ... a huge impact on businesses and individual consumers alike. Laboratories can maximize their ... a value anywhere from $4 trillion to $11 trillion dollars by the year 2025. ...
(Date:3/23/2017)... TX (PRWEB) , ... March 23, 2017 , ... March ... organs that pack a punch when it comes to maintaining good health. Every day, ... 30 minutes, your kidneys filter every drop of your blood, eliminating waste, regulating fluid ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... program owned and organized by HMP Communications Holdings, LLC, today announced that ... within its nationwide network of wound centers interested in becoming Certified Wound Specialist ...
(Date:3/23/2017)... ... March 23, 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) ... travel pillow in crowdfunding history, has established a U.S. Headquarters in New York ... to Americans. , “We’re excited to be operating on U.S. shores, where most of ...
(Date:3/23/2017)... Grants Pass, OR (PRWEB) , ... March 23, 2017 , ... ... Power of Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on ... 22nd, but she also used the occasion to remind listeners of an important distinction. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 Newborns are highly ... most vaccines because their young immune systems typically ... Children,s Hospital report achieving strong vaccine responses in ... model before human trials — by adding compounds ... In two simultaneous papers, they also describe improved ...
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories ... in its licensed production facility under the Access to ... Hamilton, Ontario . The ... in October 2016, is currently operating at half capacity, ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 /PRNewswire/ ... the NASDAQ Composite ended the trading session at ... edged 0.03% lower, to finish at 20,661.30; and ... 0.19%. Gains were broad based as six out ... This Thursday, Stock-Callers.com has initiated reports coverage on ...
Breaking Medicine Technology: